array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(641) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(83) "Elanco expands board of directors with two new directors According to Investing.com" ["snippet_en"]=> string(60) "Elanco expands its board of directors with two new directors" ["url"]=> string(109) "https://vn.investing.com/news/company-news/elanco-mo-rong-hoi-dong-quan-tri-voi-hai-giam-doc-moi-93CH-2108021" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2024-04-01" ["categories"]=> array(6) { [0]=> string(13) "Collaboration" [1]=> string(12) "Board Change" [2]=> string(18) "Board Compensation" [3]=> string(14) "Product Launch" [4]=> string(18) "Expansion & Growth" [5]=> string(21) "Shareholders Feedback" } } [1]=> array(7) { ["title_en"]=> string(82) "President and CEO at IDEXX Laboratories Exercises Options Worth $6.59M By Benzinga" ["snippet_en"]=> string(70) "President and CEO at IDEXX Laboratories Exercises Options Worth $6.59M" ["url"]=> string(124) "https://uk.investing.com/news/stock-market-news/president-and-ceo-at-idexx-laboratories-exercises-options-worth-659m-3146119" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2023-09-06" ["categories"]=> array(2) { [0]=> string(9) "Valuation" [1]=> string(12) "Board Change" } } [2]=> array(7) { ["title_en"]=> string(52) "More change at the top at Norbrook as CEO Nagle goes" ["snippet_en"]=> string(174) "LIAM Nagle will stand down from his role as chief executive of Newry-based veterinary pharma firm Norbrook Laboratories at the end of this year, but will stay on as chairman." ["url"]=> string(111) "http://www.irishnews.com/business/2023/09/06/news/more_change_at_the_top_at_norbrook_as_ceo_nagle_goes-3586566/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b9bb139c-7034-46e5-95ad-475b35e7612a" ["source"]=> string(13) "irishnews.com" ["publication_date"]=> string(10) "2023-09-05" ["categories"]=> array(2) { [0]=> string(10) "Executives" [1]=> string(12) "Board Change" } } [3]=> array(7) { ["title_en"]=> string(65) "IDEXX Laboratories Elects Irene Chang Britt to Board of Directors" ["snippet_en"]=> string(277) "WESTBROOK, Maine, July 12, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company's Board of Directors, effective July 11, 2023." ["url"]=> string(83) "https://finance.yahoo.com/news/idexx-laboratories-elects-irene-chang-110000561.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ffcb6e00-79d5-4858-a686-8150d13f476a" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-07-12" ["categories"]=> array(1) { [0]=> string(12) "Board Change" } } [4]=> array(7) { ["title_en"]=> string(94) "IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2022 Results - Earnings Call Transcript" ["snippet_en"]=> string(128) "Q2 2022 Earnings Conference Call August 02, 2022 08:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief" ["url"]=> string(130) "https://ourcommunitynow.com/news-business/idexx-laboratories-inc-idxx-ceo-jay-mazelsky-on-q2-2022-results-earnings-call-transcript" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ab88294a-2aff-4efe-bb01-67ae4084e5b9" ["source"]=> string(19) "ourcommunitynow.com" ["publication_date"]=> string(10) "2022-08-02" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(12) "Board Change" } } [5]=> array(7) { ["title_en"]=> string(71) "Ocular Therapeutix™ Appoints Merilee Raines to Its Board of Directors" ["snippet_en"]=> string(150) "Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative thera" ["url"]=> string(134) "https://www.businesswire.com/news/home/20210922005315/en/Ocular-Therapeutix%E2%84%A2-Appoints-Merilee-Raines-to-Its-Board-of-Directors" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c4bf2b24-ec83-4e7c-a64a-d1b54ab67d7e" ["source"]=> string(16) "businesswire.com" ["publication_date"]=> string(10) "2021-09-22" ["categories"]=> array(1) { [0]=> string(12) "Board Change" } } [6]=> array(7) { ["title_en"]=> string(79) "Wolters Kluwer Nominates Sophie Vandebroek for Appointment to Supervisory Board" ["snippet_en"]=> string(156) "Wolters Kluwer Nominates Sophie Vandebroek for Appointment to Supervisory Board January 31, 2020, Wolters Kluwer today announced the nomination of Dr...." ["url"]=> string(151) "https://www.globenewswire.com/news-release/2020/01/31/1977977/0/en/Wolters-Kluwer-Nominates-Sophie-Vandebroek-for-Appointment-to-Supervisory-Board.html" ["image_url"]=> NULL ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2020-01-31" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(25) "Leadership and Governance" [2]=> string(12) "Board Change" } } [7]=> array(7) { ["title_en"]=> string(47) "Idexx’s Ayers steps down as CEO and president" ["snippet_en"]=> string(155) "Jay Mazelsky has been named president and CEO of Idexx Laboratories Inc. four months after longtime chief Jonathan Ayers was injured in a bicycle accident." ["url"]=> string(82) "https://todaysveterinarybusiness.com/idexxs-ayers-steps-down-as-ceo-and-president/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/712cda03-576a-4c46-a548-6ad70e45338c" ["source"]=> string(28) "todaysveterinarybusiness.com" ["publication_date"]=> string(10) "2019-10-24" ["categories"]=> array(5) { [0]=> string(12) "Board Change" [1]=> string(20) "Corporate Governance" [2]=> string(8) "Downtime" [3]=> string(12) "Staff hiring" [4]=> string(10) "Executives" } } [8]=> array(7) { ["title_en"]=> string(59) "IDEXX Laboratories to Present at J.P. Morgan Healthcare ..." ["snippet_en"]=> string(252) "20-12-2016· WESTBROOK, Maine, December 20, 2016— IDEXX Laboratories, Inc.( NASDAQ: IDXX) announced today that it will participate in the 35th Annual J.P. Morgan Healthcare Conference.Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled" ["url"]=> string(126) "https://www.idexx.com/en/about-idexx/news/newsroom-archive/idexx-laboratories-present-jp-morgan-healthcare-conference-dec2016/" ["image_url"]=> NULL ["source"]=> string(9) "idexx.com" ["publication_date"]=> string(10) "2016-12-20" ["categories"]=> array(1) { [0]=> string(12) "Board Change" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(117) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(65) } [2]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(43) } [3]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc